Vanda Pharmaceuticals Reports Third Quarter 2016 Financial Results
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/14/2026
- S&P 500 ends lower as investors weigh data, Middle East tensions
- BofA's Hartnett explains why Wall Street is trading with 'no fear'
- Oil rises after US threatens indefinite blockade of Iran; set for weekly gains
- Are KOSPI and SOX in a bubble? Citi answers
- Could Intel return to the red-hot memory market after $20B raise and recent hire?
Vanda Pharmaceuticals (VNDA) Tops Q3 EPS by 10c
November 2, 2016 5:01 PM EDTVanda Pharmaceuticals (NASDAQ: VNDA) reported Q3 EPS of ($0.01), $0.10 better than the analyst estimate of ($0.11). Revenue for the quarter came in at $38.5 million versus the consensus estimate of $38.05 million.
Cash, cash equivalents and marketable securities (Cash) were $142.6 million as of September 30, 2016, representing... More
